These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4990534)

  • 1. [High dosage carbenicillin-treatment of urinary infections].
    Kierfeld G; Kierfeld E
    Med Welt; 1970 Oct; 42():1820-4. PubMed ID: 4990534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effective treatment of urinary tract infection with carbenicillin].
    Yamamoto C; Miyoshi T; Namikawa K; Fukuchi S
    Hinyokika Kiyo; 1971 Sep; 17(9):596-600. PubMed ID: 5001081
    [No Abstract]   [Full Text] [Related]  

  • 3. [1st personal experiences with carbenicillin therapy of urinary tract infections due to Pseudomonas aeruginosa].
    De Rosa F
    G Mal Infett Parassit; 1971 Nov; 23(11):1068-70. PubMed ID: 5004854
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials of carbenicillin therapy in infections due to Pseudomonas aeruginosa].
    Malfatti S; Pardini C; Silvi G
    G Mal Infett Parassit; 1971 Nov; 23(11):1063-8. PubMed ID: 5004853
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin.
    Smith CB; Wilfert JN; Dans PE; Kurrus TA; Finland M
    J Infect Dis; 1970 Sep; 122():Suppl:S14-28. PubMed ID: 4990023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences in treatment of Pyocyaneus infections of the urinary tract by carbenicillin].
    Gritz K; Naumann P
    Arzneimittelforschung; 1969 Aug; 19(8):1237-41. PubMed ID: 4980238
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro action and clinical use of indanyl carbenicillin].
    Fontana G; Laudi M; Sesia G; Savoia D; Cauda F
    Minerva Urol; 1976; 28(6):285-8. PubMed ID: 827680
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudomonas aeruginosa and proteus infections in premature babies and in infants. Therapeutic trial with carbenicillin.
    Korányi G; Pesti E; Somogyi G
    Acta Paediatr Acad Sci Hung; 1970; 11(2):141-50. PubMed ID: 4994152
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of kasugamycin in urinary tract infection, especially against Pseudomonas aeruginosa].
    Tada S; Hakamada T; Mori O; Yamazaki Y
    Hinyokika Kiyo; 1968 Jan; 14(1):50-6. PubMed ID: 4971183
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the therapy of spontaneous and antibiotic-induced simple and multiple changes in the causative agents of urinary tract infection as well as the therapy of the resistance of these agents to antibiotics].
    Chwalla R
    Z Urol Nephrol; 1965 Jun; 58(6):375-80. PubMed ID: 4953703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical-pharmacological study of the new semi-synthetic penicillin preparation, carbenicillin, in urologic patients. Relations between blood and tissue concentration of carbenicillin].
    Iván E; Földi J; Arr M; Molnár I; Biró L
    Z Urol Nephrol; 1970 Apr; 63(4):241-6. PubMed ID: 4943703
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbenicillin, clinicolaboratory experience.
    Daïkos GD; Kontomichalou P; Zerefos N; Caralampidou A; Papachristou E
    Chemotherapy; 1970; 15(1):45-51. PubMed ID: 4985486
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of mezlocillin and carbenicillin as therapy for various infectious diseases.
    Rolandi E; Barreca T; Ragni N; Valente U; Sannia A; Fontana I; Magnani G; Salvini P
    Clin Ther; 1981; 4(4):321-5. PubMed ID: 6460558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carbenicillin in the therapy of urinary infections by gram-negative bacteria].
    De Rosa F; Di Nardo V; Lotti T
    Clin Ter; 1970 Nov; 55(4):339-43. PubMed ID: 5516890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of gentamicin and other therapeutic drugs on the causative agents in urinary tract infections. 10-year report].
    Schmid W
    Med Welt; 1980 Jan; 31(1):32-6. PubMed ID: 6770223
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with azlocillin].
    Baisch C; Grimm H; Schmidt D; Suhayda A
    Med Welt; 1979 Nov; 30(47):1790-3. PubMed ID: 514049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of indanyl-carbenicillin (CP 15,464) following oral administration in man].
    Burgy C
    Schweiz Med Wochenschr; 1972 May; 102(21):732-8. PubMed ID: 4630209
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carbenicillin in the treatment of urinary infections].
    Comeri G; Passera R; Bortoluzzi E
    Minerva Med; 1971 Apr; 62(32):1658-68. PubMed ID: 5577297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary tract infections due to multiresistant gram negative bacteria].
    Acar JF; Guibert J; Bourquelot P; Brisset JM
    Nouv Presse Med; 1974 Apr; 3(0):69-72. PubMed ID: 4209339
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application of carbenicillin in the Gram-negative infections].
    Danieli G; Montroni M
    Clin Ter; 1971 Apr; 57(1):49-62. PubMed ID: 4996911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.